We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MB:MILMediobanca - Banca di Credito Finanziario S.p.A. Analysis

Data as of 2026-06-11 - not real-time

€24.61

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mediobanca is trading at €24.61, just below the calculated resistance of €25.54 and comfortably above the 20‑day SMA of €21.74, indicating a bullish short‑term trend. However, the RSI is perched at 76, signaling an overbought condition, and the recent Q1 earnings miss (net income €322.7 million vs €334 million a year ago) nudged the stock down 1.1% on the day. Operating margins of 54% and a profit margin of 39% underline strong profitability, while the PE of 16.7 is roughly in line with the industry average of 16.5, suggesting a fair valuation despite the price being above analyst target levels. The dividend yield remains attractive at 5.05% with a payout ratio of 78%, supported by a hefty cash pile of €26.4 billion, making the dividend appear sustainable.
Looking ahead, the low beta of 0.38 points to limited price volatility relative to the market, but a 30‑day volatility of 39% and a max drawdown of 30% highlight notable downside risk. The stock’s solid dividend, robust operating performance, and bullish technical signals favor a medium‑ to long‑term buy stance, while the overbought RSI and proximity to resistance advise a cautious hold in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Price near resistance level
  • Recent earnings miss

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and SMA alignment
  • High dividend yield with strong cash base
  • Operating margins above 50%

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend payout
  • Low beta indicating defensive profile
  • Consistent profitability and fair valuation

Key Metrics & Analysis

Financial Health

Revenue Growth0.50%
Profit Margin39.08%
P/E Ratio16.7
P/B Ratio1.7
Industry P/E16.5

Technical Analysis

TrendBullish
RSI76.3
Support€20.32
Resistance€25.54
MA 20€21.74
MA 50€20.16
MA 200€18.34
MACDBullish
VolumeIncreasing
Fear & Greed Index81.75

Valuation

Target Price€21.77
Upside/Downside-11.53%
GradeFair
TypeBlend
Dividend Yield5.05%

Risk Assessment

Beta0.39
Volatility39.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.